• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内皮素受体拮抗剂SB 217242可减轻局灶性脑缺血性脑损伤。

The endothelin receptor antagonist SB 217242 reduces cerebral focal ischemic brain injury.

作者信息

Barone F C, White R F, Elliott J D, Feuerstein G Z, Ohlstein E H

机构信息

Department of Cardiovascular Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406, USA.

出版信息

J Cardiovasc Pharmacol. 1995;26 Suppl 3:S404-7.

PMID:8587428
Abstract

Previously, we demonstrated that cerebral focal ischemic tissue exhibits a significant increase in immunoreactive endothelin (ET). Because increased ET might exacerbate the consequences of cerebral ischemia, we evaluated the effects of the orally active ETA/B receptor antagonist SB 217242 on middle cerebral artery occlusion (MCAO) in the spontaneously hypertensive rat (SHR). SHRs were treated b.i.d. with vehicle or with 3 or 15 mg/kg SB 217242 p.o. for 7 days. Permanent MCAO was performed on day 7 and animals were sacrificed on day 8. Forebrains were stained and the extent of cerebral (i.e., cortical) infarction was determined using image analysis. Hemispheric swelling (%), hemispheric infarct (%), and infarct volume (mm3) were quantitated for each animal. SB 217242 treatment produced a significant decrease in ischemic brain injury. Hemispheric infarction and infarct volume were reduced after the 15 mg/kg treatment (12.0 +/- 1.1% and 69 +/- 6 mm3) compared to vehicle (17.3 +/- 1.5% and 99 +/- 8 mm3) (p < 0.05). No significant effects on hemispheric swelling were observed. This is the first demonstration of an ET receptor antagonist exhibiting efficacy in cerebral focal ischemia. The fact that a 30% reduction in ischemic brain injury can be demonstrated after oral administration of SB 217242 suggests that ET antagonists may be of therapeutic utility in focal stroke.

摘要

此前,我们证明脑局灶性缺血组织中免疫反应性内皮素(ET)显著增加。由于ET增加可能会加重脑缺血的后果,我们评估了口服活性ETA/B受体拮抗剂SB 217242对自发性高血压大鼠(SHR)大脑中动脉闭塞(MCAO)的影响。将SHR每日两次用赋形剂或3或15mg/kg SB 217242口服治疗7天。在第7天进行永久性MCAO,并在第8天处死动物。对前脑进行染色,并使用图像分析确定脑(即皮质)梗死的范围。对每只动物的半球肿胀(%)、半球梗死(%)和梗死体积(mm³)进行定量。SB 217242治疗使缺血性脑损伤显著减轻。与赋形剂组(17.3±1.5%和99±8mm³)相比,15mg/kg治疗后半球梗死和梗死体积减小(12.0±1.1%和69±6mm³)(p<0.05)。未观察到对半球肿胀有显著影响。这是首次证明ET受体拮抗剂在脑局灶性缺血中具有疗效。口服SB 217242后可证明缺血性脑损伤减少30%,这一事实表明ET拮抗剂可能对局灶性中风具有治疗作用。

相似文献

1
The endothelin receptor antagonist SB 217242 reduces cerebral focal ischemic brain injury.内皮素受体拮抗剂SB 217242可减轻局灶性脑缺血性脑损伤。
J Cardiovasc Pharmacol. 1995;26 Suppl 3:S404-7.
2
SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.SB 234551选择性内皮素A(ET(A))受体拮抗作用:灌注/扩散磁共振成像用于定义可治疗性中风模型、治疗时间及保护机制。
Exp Neurol. 2008 Jul;212(1):53-62. doi: 10.1016/j.expneurol.2008.03.011. Epub 2008 Mar 25.
3
A selective endothelin ET(A) receptor antagonist, SB 234551, improves cerebral perfusion following permanent focal cerebral ischemia in rats.一种选择性内皮素ET(A)受体拮抗剂SB 234551可改善大鼠永久性局灶性脑缺血后的脑灌注。
Brain Res. 2005 May 31;1045(1-2):150-6. doi: 10.1016/j.brainres.2005.03.025. Epub 2005 Apr 15.
4
Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist.非肽类内皮素受体拮抗剂。VI:强效且生物利用度高的内皮素受体拮抗剂SB 217242的药理学特性。
J Pharmacol Exp Ther. 1996 Feb;276(2):609-15.
5
Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats.脑室内注射脑源性神经营养因子可减小大鼠局灶性脑缺血后的梗死面积。
J Cereb Blood Flow Metab. 1997 May;17(5):500-6. doi: 10.1097/00004647-199705000-00003.
6
High-dose methylprednisolone treatment in experimental focal cerebral ischemia.实验性局灶性脑缺血的大剂量甲基强的松龙治疗
Exp Neurol. 2001 Jan;167(1):166-72. doi: 10.1006/exnr.2000.7532.
7
Protective effect of the novel cerebrovascular-selective calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate on ischemic brain damage after permanent middle cerebral artery occlusion in rats.新型脑血管选择性钙拮抗剂(±)-(E)-1-(3-氟-6,11-二氢二苯并[b,e] - 氧杂卓-11-基)-4-(3-苯基-2-丙烯基)-哌嗪二马来酸盐对大鼠大脑中动脉永久性闭塞后缺血性脑损伤的保护作用
Arzneimittelforschung. 1996 Jun;46(6):567-71.
8
Post-treatment of transient focal cerebral ischemia in rats with the novel cerebrovascular-selective Ca2+ channel antagonist (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-pheny l-2-propenyl)-piperazine dimaleate.用新型脑血管选择性钙通道拮抗剂(±)-(E)-1-(3-氟-6,11-二氢二苯并[b,e]氧杂卓-11-基)-4-(3-苯基-2-丙烯基)-哌嗪二马来酸盐对大鼠短暂性局灶性脑缺血进行治疗后
Arzneimittelforschung. 1997 Jul;47(7):799-802.
9
Repeated administration of exendin-4 reduces focal cerebral ischemia-induced infarction in rats.重复给予 exendin-4 可减少大鼠局灶性脑缺血引起的梗死。
Brain Res. 2012 Jan 3;1427:23-34. doi: 10.1016/j.brainres.2011.10.026. Epub 2011 Oct 19.
10
Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia.艾芬地尔和SL 82.0715作为脑缺血治疗药物。I. 局灶性脑缺血模型中的疗效证据。
J Pharmacol Exp Ther. 1988 Dec;247(3):1211-21.

引用本文的文献

1
Sovateltide (ILR-1620) Improves Motor Function and Reduces Hyperalgesia in a Rat Model of Spinal Cord Injury.Sovateltide(ILR-1620)改善脊髓损伤大鼠模型的运动功能并减轻痛觉过敏。
Neurocrit Care. 2024 Oct;41(2):455-468. doi: 10.1007/s12028-024-01950-2. Epub 2024 Mar 5.
2
Neuroprotective Effect of IRL-1620, an Endothelin B Receptor Agonist, on a Pediatric Rat Model of Middle Cerebral Artery Occlusion.内皮素B受体激动剂IRL-1620对小儿大脑中动脉闭塞大鼠模型的神经保护作用
Front Pediatr. 2018 Oct 23;6:310. doi: 10.3389/fped.2018.00310. eCollection 2018.
3
Endothelin-1, aging and hypertension.
内皮素-1、衰老与高血压
Curr Opin Cardiol. 2008 Jul;23(4):350-5. doi: 10.1097/HCO.0b013e328302f3c6.
4
Endothelin receptor antagonists and cardiovascular diseases of aging.内皮素受体拮抗剂与衰老相关心血管疾病
Drugs Aging. 2001;18(6):425-40. doi: 10.2165/00002512-200118060-00005.
5
Different endothelins stimulate cytokine production by peritoneal macrophages and microglial cell line.不同的内皮素可刺激腹膜巨噬细胞和小胶质细胞系产生细胞因子。
Immunology. 1998 Jan;93(1):109-14. doi: 10.1046/j.1365-2567.1998.00391.x.
6
Contractile effect of big endothelin-1 and its conversion to endothelin-1 in rabbit cerebral arteries.大内皮素-1在兔脑动脉中的收缩作用及其向内皮素-1的转化
Naunyn Schmiedebergs Arch Pharmacol. 1996 Nov;354(5):656-61. doi: 10.1007/BF00170842.